Lotte A. Stiekema

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

miR-499 in Platelet-Derived Extracellular Vesicles Augments Inflammatory Cell Generation and Cardiac Remodeling After Myocardial Infarction.

miR-499 in Platelet-Derived Extracellular Vesicles Augments Inflammatory Cell Generation and Cardiac Remodeling After Myocardial Infarction.

Journal: Circulation

Published: November 10, 2025

Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation.

Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: January 25, 2024

Peripheral Ischemia Imprints Epigenetic Changes in Hematopoietic Stem Cells to Propagate Inflammation and Atherosclerosis.

Peripheral Ischemia Imprints Epigenetic Changes in Hematopoietic Stem Cells to Propagate Inflammation and Atherosclerosis.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: March 09, 2023

Impact of cholesterol on proinflammatory monocyte production by the bone marrow.

Impact of cholesterol on proinflammatory monocyte production by the bone marrow.

Journal: European heart journal

Published: October 25, 2020

Short-term regulation of hematopoiesis by lipoprotein(a) results in the production of pro-inflammatory monocytes.

Short-term regulation of hematopoiesis by lipoprotein(a) results in the production of pro-inflammatory monocytes.

Journal: International journal of cardiology

Published: March 16, 2020

Metabolic effects of PCSK9 inhibition with Evolocumab in subjects with elevated Lp(a).

Metabolic effects of PCSK9 inhibition with Evolocumab in subjects with elevated Lp(a).

Journal: Lipids in health and disease

Published: March 05, 2020

The therapeutic age paradox coming to an end.

The therapeutic age paradox coming to an end.

Journal: European heart journal

Published: December 19, 2019

Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a).

Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a).

Journal: European heart journal

Published: October 24, 2019

PCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers.

PCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers.

Journal: JACC. Cardiovascular imaging

Published: April 12, 2019

Treatment with Statins Does Not Revert Trained Immunity in Patients with Familial Hypercholesterolemia.

Treatment with Statins Does Not Revert Trained Immunity in Patients with Familial Hypercholesterolemia.

Journal: Cell metabolism

Published: March 14, 2019

Plaque Permeability Assessed With DCE-MRI Associates With USPIO Uptake in Patients With Peripheral Artery Disease.

Plaque Permeability Assessed With DCE-MRI Associates With USPIO Uptake in Patients With Peripheral Artery Disease.

Journal: JACC. Cardiovascular imaging

Published: December 31, 2018

Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment.

Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment.

Journal: European heart journal

Published: October 05, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026